Somnigroup International Inc.

• SGI Stock Price 24h change: +1.09%. From 92.98 USD to 94.00 USD. This rise was driven by a record high reaching 95.46 USD earlier in the session, reflecting strong investor confidence and solid sales growth momentum.
• From a technical perspective, SGI exhibits a "Strong Buy" setup with a technical score of 7/10. The stock is in a confirmed long-term uptrend, trading above its 50-day and 200-day moving averages, though short-term RSI levels suggest it is approaching overbought territory after testing its 52-week resistance.
• Somnigroup International announced an all-stock proposal to acquire Leggett & Platt (LEG), a strategic move aimed at consolidating its supply chain and expanding its bedding manufacturing footprint.
• UBS reiterated its "Buy" rating on SGI with a price target of $110, citing potential earnings accretion from the Mattress Firm acquisition and continued market share gains in the premium sleep segment.
• Somnigroup confirmed it will report its Q4 and full-year 2025 financial results on February 17, 2026, with analysts expecting a 60%+ year-over-year revenue increase driven by omnichannel expansion.
• In the broader consumer durables and healthcare sector, NHS England launched a "sprint" initiative to clear elective surgery backlogs, potentially boosting demand for specialized hospital bedding and medical furnishings.
• RBC Capital Markets issued a cautious outlook for the medical device sector in 2026, citing cost pressures and competitive threats, while favoring "strong near-term earnings" stocks like ResMed and CSL over smaller industry peers.

• SGI Stock Price 24h change: +0.89%. From 93.17 USD to 94.00 USD.
• Somnigroup (SGI) shares closed higher as Leggett & Platt authorized discussions and signed a non-disclosure agreement to allow due diligence on SGI's $1.6 billion all-stock acquisition proposal.
• Technical analysis indicates a "strong buy" momentum with SGI trading above its 50-day (89.97) and 200-day (77.06) moving averages. RSI at 59.87 suggests a healthy bullish trend without being overbought, while a recent "pocket pivot" signals strong accumulation by institutional investors.
• On January 20, 2026, Somnigroup confirmed Leggett & Platt's board authorized formal discussions and due diligence regarding SGI's acquisition offer of $12 per share.
• Somnigroup announced it will release its fourth quarter and full year 2025 financial results on January 15, following a year of record sales growth driven by its Tempur Sealy and Mattress Firm units.
• Major institutional investors including Allspring Global and NISA Investment Advisors significantly raised their stakes in SGI during the first weeks of January, citing strong fundamental growth momentum.
• The EU proposed new measures to reduce administrative burdens and support innovation for medical device manufacturers to streamline product launches across Europe.
• The FDA issued a public service update regarding Abbott's medical device correction for specific glucose sensors, highlighting increased regulatory focus on technovigilance and consumer safety in early 2026.